• Mashup Score: 18

    This article highlights key advances in the treatment of acute myeloid leukemia, specifically menin inhibitors for relapsed disease and retinoic acid/arsenic-based therapy for high-risk acute promyel…

    Tweet Tweets with this article
    • This commentary by @rahul2u and @EuniceWangMD of @RoswellPark highlights key advances for acute myeloid leukemia in 2024, including novel cancer drug approvals & other advances supporting the #PrecisionMedicine paradigm shift for #AML therapy. https://t.co/sqwhHHbI07 @OncoAlert https://t.co/ifsHzzlKfa

  • Mashup Score: 18

    This article highlights key advances in the treatment of acute myeloid leukemia, specifically menin inhibitors for relapsed disease and retinoic acid/arsenic-based therapy for high-risk acute promyel…

    Tweet Tweets with this article
    • This commentary by @rahul2u and @EuniceWangMD of @RoswellPark highlights key advances for acute myeloid leukemia in 2024, including novel cancer drug approvals & other advances supporting the #PrecisionMedicine paradigm shift for #AML therapy. https://t.co/sqwhHHbI07 @OncoAlert https://t.co/ifsHzzlKfa